Xiao-Min Ou (Xiaomin Ou)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 14

Top Topics

Locally Advanced

Inflammatory Response

Top Venues

Cancer immunology research

Cell death & disease

Journal of the National Cancer Institute

Current cancer drug targets

This page only lists publications with an associated author ORCID identifier.

Publications

Xiao-Min Ou, Yingzi Zhang, Yiqing Xu, Yi Liu, Wenzhi Tu, Chaosu Hu, Yong Liu
PICK1 inhibits the malignancy of nasopharyngeal carcinoma and serves as a novel prognostic marker. Cell death & disease 15 (4) (2024)
Baomin Zheng, Meilin He, Yaqian Han, Xin Jiang, Xiao-Min Ou, Peng Zhang, Ruyuan Guo, Jin-Gao Li, Xi-Mei Zhang, Qiao Qiao, Hui Wu, Man Hu, Mei Feng, Wenyong Tu, Jun-Lin Yi
Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis. Current cancer drug targets (2024)
Da-Feng Lin, Hai-Lin Li, Ting Liu, Xiao-Fei Lv, Chuan-Miao Xie, Xiao-Min Ou, Jian Guan, Ye Zhang, Wen-Bin Yan, Mei-Lin He, Meng-Yuan Mao, Xun Zhao, Lian-Zhen Zhong, Wen-Hui Chen, Qiu-Yan Chen, Hai-Qiang Mai, Rou-Jun Peng, Jie Tian, Lin-Quan Tang, Di Dong
Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma. Journal of the National Cancer Institute 116 (8) (2024)
Xiao-Min Ou, Yingzi Zhang, Yiqing Xu, Yi Liu, Wenzhi Tu, Chaosu Hu, Yong Liu
PICK1 inhibits the malignancy of nasopharyngeal carcinoma and serves as a novel prognostic marker. Cell death & disease 15 (4) (2024)
Da-Feng Lin, Hai-Lin Li, Ting Liu, Xiao-Fei Lv, Chuan-Miao Xie, Xiao-Min Ou, Jian Guan, Ye Zhang, Wen-Bin Yan, Mei-Lin He, Meng-Yuan Mao, Xun Zhao, Lian-Zhen Zhong, Wen-Hui Chen, Qiu-Yan Chen, Hai-Qiang Mai, Rou-Jun Peng, Jie Tian, Lin-Quan Tang, Di Dong
Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma. Journal of the National Cancer Institute 116 (8) (2024)
Baomin Zheng, Meilin He, Yaqian Han, Xin Jiang, Xiao-Min Ou, Peng Zhang, Ruyuan Guo, Jin-Gao Li, Xi-Mei Zhang, Qiao Qiao, Hui Wu, Man Hu, Mei Feng, Wenyong Tu, Jun-Lin Yi
Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis. Current cancer drug targets 24 (9) (2024)
Xiao-Min Ou, Yingzi Zhang, Yiqing Xu, Yi Liu, Wenzhi Tu, Chaosu Hu, Yong Liu
PICK1 inhibits the malignancy of nasopharyngeal carcinoma and serves as a novel prognostic marker. Cell death & disease 15 (4) (2024)
Xiao-Min Ou, Yingzi Zhang, Yiqing Xu, Yi Liu, Wenzhi Tu, Chaosu Hu, Yong Liu
PICK1 inhibits the malignancy of nasopharyngeal carcinoma and serves as a novel prognostic marker. Cell death & disease 15 (4) (2024)
Ye Wei, Tingting Xu, Chong Li, Xin Zhou, Wei Qian, Chunying Shen, Qifeng Wang, Xing Xing, Xiao-Min Ou, Xiayun He, Hong-Mei Ying, Chaosu Hu, Shuwen Yang, Qinghai Ji, Fengtao Su, Xueguan Lu
CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer. Cancer immunology research 11 (3) (2023)
Xiao-Min Ou, Ruiping Zhai, Wenjun Wei, Jiaying Chen, Dan Ou, Tian Liao, Tingting Xu, Yongxue Zhu, Yu-Long Wang, Shengling Huang, Rongliang Shi, Bin Wu, Tongzhen Chen, Yuan Li, Zhongyi Yang, Changming Zhou, Yuan Liu, Ziting Jiang, Min Zeng, Xin Liu, Dongmei Ji, Hong-Mei Ying, Zhen Zhang, Chaosu Hu, Xueguan Lu, Qinghai Ji, Xiayun He, Yu Wang
Induction Toripalimab And Chemotherapy For Organ Preservation In Locally Advanced Laryngeal And Hypopharyngeal Cancer: A Single-Arm Phase 2 Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ye Wei, Tingting Xu, Chong Li, Xin Zhou, Wei Qian, Chunying Shen, Qifeng Wang, Xing Xing, Xiao-Min Ou, Xiayun He, Hong-Mei Ying, Chaosu Hu, Shuwen Yang, Qinghai Ji, Fengtao Su, Xueguan Lu
CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer. Cancer immunology research 11 (3) (2023)
Ye Wei, Tingting Xu, Chong Li, Xin Zhou, Wei Qian, Chunying Shen, Qifeng Wang, Xing Xing, Xiao-Min Ou, Xiayun He, Hong-Mei Ying, Chaosu Hu, Shuwen Yang, Qinghai Ji, Fengtao Su, Xueguan Lu
CD161 characterizes an inflamed subset of cytotoxic T lymphocytes associated with prolonged survival in human papillomavirus-driven oropharyngeal cancer. Cancer immunology research (2023)
Ye Wei, Tingting Xu, Chong Li, Xin Zhou, Wei Qian, Chunying Shen, Qifeng Wang, Xing Xing, Xiao-Min Ou, Xiayun He, Hong-Mei Ying, Chaosu Hu, Shuwen Yang, Qinghai Ji, Fengtao Su, Xueguan Lu
CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer. Cancer immunology research 11 (3) (2023)
Ye Wei, Tingting Xu, Chong Li, Xin Zhou, Wei Qian, Chunying Shen, Qifeng Wang, Xing Xing, Xiao-Min Ou, Xiayun He, Hong-Mei Ying, Chaosu Hu, Shuwen Yang, Qinghai Ji, Fengtao Su, Xueguan Lu
CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer. Cancer immunology research 11 (3) (2023)